Met Life Investment Management, LLC Kymera Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 25,888 shares of KYMR stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,888
Previous 25,888
-0.0%
Holding current value
$1.1 Million
Previous $772,000
58.68%
% of portfolio
0.01%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$282 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$254 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$219 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$208 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$202 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.32B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...